Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fda383378cdfb585182f89a0fd68b5ba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2537af7c22a987ef3a746dc6ccdfc2 |
publicationDate |
2020-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112020008001-A2 |
titleOfInvention |
anti-glyco-muc1 antibody or antigen-binding fragment, fusion protein, chimeric antigen receptor, antibody-drug conjugate, nucleic acid, vector, host cell, pharmaceutical composition, and methods of treating cancer and detecting cancer in a biological sample. |
abstract |
the present description relates to anti-glyco-muc1 antibodies and antigen-binding fragments thereof that specifically bind to a specific glycosylation variant of muc1 cancer and related fusion proteins and antibody-drug conjugates, as well as nucleic acids encoding such biomolecules. the present description further refers to the use of antibodies, antigen-binding fragments, fusion proteins, antibody-drug conjugates and nucleic acids for cancer therapy. |
priorityDate |
2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |